Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

A new medical study published this month suggests yes — with some key factors to keep in mind. Ozempic’s long-term impact.

The demand for weight loss medications are on the rise, and now, “natural” GLP-1s are being marketed to help you lose weight.

The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

GLP-1 supplements are advertised as a cheaper alternative to weight loss with Ozempic or Wegovy. Doctors explain if they help ...

在全球药物市场中，GLP-1类减肥药物正迅速崛起，成为万亿美元市场上的新星。根据晨星公司和Pitchbook的一份报告，预计到2029年，将有高达16种新的GLP-1类减肥药物上市。这一现象引发了广泛关注，尤其是在一个潜在的2000亿美元市场中，这些新药可能占据近三分之一的份额。那么，诺和诺德（NVO.US）和礼来（LLY.US）是否能够继续保持市场的领导地位呢？

诺和诺德声称其有效成分为利拉鲁肽的减肥药物对12岁以下的儿童安全且有效。 利拉鲁肽（liraglutide）很可能成为全球首个用于治疗低龄儿童肥胖症的药物。 目前，市面上尚无用于治疗12岁以下儿童肥胖症的药物获批。

9月17日，圣诺生物公告，公司签订不超3.5亿元胰高糖素样肽-1（GLP-1）多肽原料药供货合同。另从前不久发布完毕的半年报来看，圣诺生物也成为了为数不多实现业绩增长的CXO（医药外包）企业。

Can a popular medication used to change your body also be affecting your mood? It’s a question that some users of semaglutide ...

As GLP-1 weight loss drugs fly off shelves, Kourtney Kardashian Barker is getting in on the hustle — well, sort of.

对Ozempic和Wegovy减肥药用户来说，减肥成了疯狂购物的理由，奢侈品经销商也在密切关注。二手奢侈品时尚市场发现人们在减肥过程中会更新衣柜，而减肥药物日益普及可能加快趋势。 据《Vogue ...